HB 764 KY Introduced
AN ACT relating to the Kentucky All Schedule Prescription Electronic Reporting system.
A state bill is a proposed law in a state legislature — separate from the U.S. Congress. Learn more →
Summary
Amend KRS 205.529 to remove reference to a Schedule III controlled substance containing hydrocodone in the program for synchronization of medications; amend KRS 218A.010 to add optometrist and physician assistant to the definition of "practitioner"; amend KRS 218A.172 to remove reference to a Schedule III controlled substance containing hydrocodone in the medications regulated; amend KRS 218A.182 to add charitable health care providers to the exemption from the requirement for an electronic prescription for a controlled substance; amend KRS 218A.202 to require an active account with the electronic monitoring system to prescribe and dispense controlled substances; amend KRS 218A.205 to remove reference to a Schedule III controlled substance containing hydrocodone in the medications regulated and prohibition on dispensing greater than a 48-hour supply of a Schedule II controlled substance; amend KRS 218A.245 to allow the cabinet to enter into contract with any federal agency of the United States; amend KRS 304.17A-165 to remove reference to a Schedule III controlled substance containing hydrocodone in the list of controlled substances allowed under a health benefit plan.
Sponsor (1)
- R. Duvall Republican · primary
Action history (7)
- Feb 26, 2024 introduced in House · lower
- Feb 26, 2024 to Committee on Committees (H) · lower
- Mar 8, 2024 to Health Services (H) · lower
- Mar 14, 2024 reported favorably, 1st reading, to Calendar · lower
- Mar 15, 2024 2nd reading, to Rules · lower
- Mar 27, 2024 taken from the Orders of the Day · lower
- Mar 27, 2024 recommitted to Appropriations & Revenue (H) · lower
Text versions (1)
Full text
The full text hasn’t been imported yet. CivicGate fetches it from the state legislature’s published version documents — check now.
Comments
Data from OpenStates. View on OpenStates →
Comments